國立虎尾科技大學 |

Databases for Pharmacoepidemiological Research

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Databases for Pharmacoepidemiological Research/ edited by Miriam Sturkenboom, Tania Schink.
其他作者:	Sturkenboom, Miriam.
面頁冊數:	IX, 280 p. 2 illus.online resource. :
Contained By:	Springer Nature eBook
標題:	Statistics . -
電子資源:	https://doi.org/10.1007/978-3-030-51455-6
ISBN:	9783030514556

Databases for Pharmacoepidemiological Research
Databases for Pharmacoepidemiological Research[electronic resource] /edited by Miriam Sturkenboom, Tania Schink. - 1st ed. 2021. - IX, 280 p. 2 illus.online resource. - Springer Series on Epidemiology and Public Health,1869-7941. - Springer Series on Epidemiology and Public Health,.

Part 1 : Databases for Phramacoepidemiological Research -- Chapter 1 – Introduction (Miriam Sturkenboom) -- Chapter 2 – Overview of databases (Iris Pigeot, Maike Tahden, Dimitrios Zampatis, Douglas J. Watson, Ulla Forssen, Bianca Kollhorst) -- Part 2 : Databases in Europe -- Chapter 3 – Clinical Practice Research Datalink (CPRD) (Melissa Myland, Caroline O’Leary, Bassam Bafadhal, Mustafa Dungarwalla, Harshvinder Bhullar, Louise Pinder, James Philpott) -- Chapter 4 – IQVIA Medical Research Data (IMRD) (Caroline O’Leary) -- Chapter 5 – The Health Service Executive – Primary Care Reimbursement Services Database in Ireland (Ireland HSE-PCRS) (Sarah-Jo Sinnott) -- Chapter 6 – Administrative Registers in Finland, Sweden, and Norway (Tuire Prami, Rosa Juuti, Ilona Iso-Mustajärvi) -- Chapter 7 – PHARMO Database Network (Ron Herings, Marina Bakker) -- Chapter 8 – German Pharmacoepidemiological Research Database (GePaRD) (Ulrike Haug, Tania Schink) -- Chapter 9 – Institute for Applied Health Research Berlin (InGef) Database (Frank Andersohn, Jochen Walker ) -- Chapter 10 – National health insurance claims database in France, Système Nationale des Données de Santé (SNDS) and Health Data Hub (HDH) (Nicholas Moore, Patrick Blin, Régis Lassalle, Nicolas Thurin, Pauline Bosco-Levy, Cécile Droz) -- Chapter 11 – Agenzia regionale di sanità della Toscana (ARS) Database (Rosa Gini).-Chapter 12 – Caserta Record Linkage Database (Gianluca Trifirò, Valentina Ientile, Janet Sultana, Michele Tari) -- Chapter 13 – Pedianet Database (Anna Cantarutti) -- Chapter 14 – BIFAP Program: A data resource for Pharmacoepidemiological research in Spain (Miguel Gil, Miguel Angel Maciá, Julio Bonis, Consuelo Huerta, Elisa Martín-Merino, Arturo Álvarez, Verónica Bryant and Dolores Montero on behalf of BIFAP Team) -- Chapter 15 – The Information System for Research in Primary Care (SIDIAP) (Talita Duarte-Salles, María Aragón, Bonaventura Bolíbar) -- Chapter 16 – Estonian Health Insurance Fund (EHIF) Database (Sirly Lätt, Helis Puksand) -- Chapter 17 – Icelandic Medicines Registry (IMR) (Larus S. Gudmundsson, Olafur B. Einarsson, Magnus Johannsson) -- Part 3 : Databases in North America -- Chapter 18 – Régie de l’assurance maladie du Québec (RAMQ) databases (Machelle Wilchesky, Samy Suissa) -- Chapter 19 – Medicaid and Medicare (Dirk Enders, Tania Schink, Til Stürmer) -- Chapter 20 – Truven Health MarketScan Research Databases (MarketScan) (Anne M. Butler, Katelin B. Nickel, Robert A. Overman, M. Alan Brookhart) -- Part 4 : Databases in Asia and Australia -- Chapter 21 – Australian Pharmaceutical Benefits Scheme (PBS) Dispensing Database (Emily A. Karanges, Melisa J. Litchfield, Leigh Mellish, Sallie-Anne Pearson) -- Chapter 22 – National Insurance Claims Database (NDB) (Daisuke Sato, Kazuhiko Ohe).-Chapter 23 – National Health Insurance (NHI) Database (K. Arnold Chan).

This book allows readers to gain an in-depth understanding of the role of real-world data in pharmacoepidemiology, and highlights the strengths and limitations of the respective databases with regard to pharmacoepidemiological research. Over the past decade, the increasing use of real-world data in pharmacoepidemiological research has been accompanied by a growing recognition of the value of real-world evidence in clinical and regulatory decision-making. Electronic healthcare databases allow analyses of drug and vaccine utilization in routine care after approval, as well as investigations of their comparative effectiveness and safety. They are especially useful for the identification of rare risks and rare drug exposures over long periods of time, and as such sustainably extend the basis for drug safety research. This book provides an introduction to the role of real-world data in pharmacoepidemiological research and the main developments in the last 15 years. It also offers a comprehensive overview of the general classification characteristics of databases, together with their strengths and limitations, and a detailed description of 21 individual databases, written by professionals who work with or maintain them. .

ISBN: 9783030514556

Standard No.: 10.1007/978-3-030-51455-6doiSubjects--Topical Terms:

1253516
Statistics .

LC Class. No.: QA276-280

Dewey Class. No.: 519.5

Databases for Pharmacoepidemiological Research
LDR:05613nam a22004215i 4500 001 1051802
003 DE-He213
005 20211025193907.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030514556 $9 978-3-030-51455-6
024 7 $a 10.1007/978-3-030-51455-6 $2 doi
035 $a 978-3-030-51455-6
050 4 $a QA276-280
072 7 $a PBT $2 bicssc
072 7 $a MED090000 $2 bisacsh
072 7 $a PBT $2 thema
072 7 $a MBNS $2 thema
082 0 4 $a 519.5 $2 23
245 1 0 $a Databases for Pharmacoepidemiological Research $h [electronic resource] / $c edited by Miriam Sturkenboom, Tania Schink.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a IX, 280 p. 2 illus. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
490 1 $a Springer Series on Epidemiology and Public Health, $x 1869-7941
505 0 $a Part 1 : Databases for Phramacoepidemiological Research -- Chapter 1 – Introduction (Miriam Sturkenboom) -- Chapter 2 – Overview of databases (Iris Pigeot, Maike Tahden, Dimitrios Zampatis, Douglas J. Watson, Ulla Forssen, Bianca Kollhorst) -- Part 2 : Databases in Europe -- Chapter 3 – Clinical Practice Research Datalink (CPRD) (Melissa Myland, Caroline O’Leary, Bassam Bafadhal, Mustafa Dungarwalla, Harshvinder Bhullar, Louise Pinder, James Philpott) -- Chapter 4 – IQVIA Medical Research Data (IMRD) (Caroline O’Leary) -- Chapter 5 – The Health Service Executive – Primary Care Reimbursement Services Database in Ireland (Ireland HSE-PCRS) (Sarah-Jo Sinnott) -- Chapter 6 – Administrative Registers in Finland, Sweden, and Norway (Tuire Prami, Rosa Juuti, Ilona Iso-Mustajärvi) -- Chapter 7 – PHARMO Database Network (Ron Herings, Marina Bakker) -- Chapter 8 – German Pharmacoepidemiological Research Database (GePaRD) (Ulrike Haug, Tania Schink) -- Chapter 9 – Institute for Applied Health Research Berlin (InGef) Database (Frank Andersohn, Jochen Walker ) -- Chapter 10 – National health insurance claims database in France, Système Nationale des Données de Santé (SNDS) and Health Data Hub (HDH) (Nicholas Moore, Patrick Blin, Régis Lassalle, Nicolas Thurin, Pauline Bosco-Levy, Cécile Droz) -- Chapter 11 – Agenzia regionale di sanità della Toscana (ARS) Database (Rosa Gini).-Chapter 12 – Caserta Record Linkage Database (Gianluca Trifirò, Valentina Ientile, Janet Sultana, Michele Tari) -- Chapter 13 – Pedianet Database (Anna Cantarutti) -- Chapter 14 – BIFAP Program: A data resource for Pharmacoepidemiological research in Spain (Miguel Gil, Miguel Angel Maciá, Julio Bonis, Consuelo Huerta, Elisa Martín-Merino, Arturo Álvarez, Verónica Bryant and Dolores Montero on behalf of BIFAP Team) -- Chapter 15 – The Information System for Research in Primary Care (SIDIAP) (Talita Duarte-Salles, María Aragón, Bonaventura Bolíbar) -- Chapter 16 – Estonian Health Insurance Fund (EHIF) Database (Sirly Lätt, Helis Puksand) -- Chapter 17 – Icelandic Medicines Registry (IMR) (Larus S. Gudmundsson, Olafur B. Einarsson, Magnus Johannsson) -- Part 3 : Databases in North America -- Chapter 18 – Régie de l’assurance maladie du Québec (RAMQ) databases (Machelle Wilchesky, Samy Suissa) -- Chapter 19 – Medicaid and Medicare (Dirk Enders, Tania Schink, Til Stürmer) -- Chapter 20 – Truven Health MarketScan Research Databases (MarketScan) (Anne M. Butler, Katelin B. Nickel, Robert A. Overman, M. Alan Brookhart) -- Part 4 : Databases in Asia and Australia -- Chapter 21 – Australian Pharmaceutical Benefits Scheme (PBS) Dispensing Database (Emily A. Karanges, Melisa J. Litchfield, Leigh Mellish, Sallie-Anne Pearson) -- Chapter 22 – National Insurance Claims Database (NDB) (Daisuke Sato, Kazuhiko Ohe).-Chapter 23 – National Health Insurance (NHI) Database (K. Arnold Chan).
520 $a This book allows readers to gain an in-depth understanding of the role of real-world data in pharmacoepidemiology, and highlights the strengths and limitations of the respective databases with regard to pharmacoepidemiological research. Over the past decade, the increasing use of real-world data in pharmacoepidemiological research has been accompanied by a growing recognition of the value of real-world evidence in clinical and regulatory decision-making. Electronic healthcare databases allow analyses of drug and vaccine utilization in routine care after approval, as well as investigations of their comparative effectiveness and safety. They are especially useful for the identification of rare risks and rare drug exposures over long periods of time, and as such sustainably extend the basis for drug safety research. This book provides an introduction to the role of real-world data in pharmacoepidemiological research and the main developments in the last 15 years. It also offers a comprehensive overview of the general classification characteristics of databases, together with their strengths and limitations, and a detailed description of 21 individual databases, written by professionals who work with or maintain them. .
650 0 $a Statistics . $3 1253516
650 0 $a Biostatistics. $3 783654
650 0 $a Pharmacy. $3 582411
650 0 $a Epidemiology. $3 635923
650 1 4 $a Statistics for Life Sciences, Medicine, Health Sciences. $3 670172
650 2 4 $a Drug Safety and Pharmacovigilance. $3 1064651
700 1 $a Sturkenboom, Miriam. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1356369
700 1 $a Schink, Tania. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1356370
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030514549
776 0 8 $i Printed edition: $z 9783030514563
776 0 8 $i Printed edition: $z 9783030514570
830 0 $a Springer Series on Epidemiology and Public Health, $x 1869-7933 $3 1267493
856 4 0 $u https://doi.org/10.1007/978-3-030-51455-6
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)